Fri Sep 26 03:40:27 UTC 2025: Okay, here’s a summary and a news article based on the provided text:

**Summary:**

US President Donald Trump has announced tariffs as high as 100% on imported branded and patented pharmaceutical products, effective October 1st. This move is expected to significantly impact India’s pharmaceutical sector, which relies heavily on trade with the United States.

**News Article:**

**Trump Announces Steep Tariffs on Imported Pharmaceuticals, India’s Drug Industry Braces for Impact**

Washington D.C. – U.S. President Donald Trump has declared the imposition of substantial tariffs, reaching up to 100%, on the import of branded and patented pharmaceutical products. The new tariffs are scheduled to take effect on October 1st, raising concerns globally, especially in India.

The Indian pharmaceutical sector, a key player in global drug manufacturing and a major exporter to the United States, is anticipated to be heavily impacted by the new policy. The industry, heavily reliant on trade with America, is assessing the potential damage and exploring strategies to mitigate the effects.

Analysts predict the tariffs could lead to increased prices for American consumers, as well as disruptions in the supply chain for vital medications. The move also raises questions about the future of trade relations between the U.S. and India, particularly within the pharmaceutical sector. The Indian government has yet to release an official statement, but industry experts are urging a swift and decisive response to protect the country’s pharmaceutical interests.

Read More